ECSP034517A - Nuevos derivados de m-amino-fenil-imino-imidazolidina para el tratamiento de la incontinencia de orina - Google Patents

Nuevos derivados de m-amino-fenil-imino-imidazolidina para el tratamiento de la incontinencia de orina

Info

Publication number
ECSP034517A
ECSP034517A EC2003004517A ECSP034517A ECSP034517A EC SP034517 A ECSP034517 A EC SP034517A EC 2003004517 A EC2003004517 A EC 2003004517A EC SP034517 A ECSP034517 A EC SP034517A EC SP034517 A ECSP034517 A EC SP034517A
Authority
EC
Ecuador
Prior art keywords
amino
treatment
imidazolidine
phenil
imino
Prior art date
Application number
EC2003004517A
Other languages
English (en)
Inventor
Franz Esser
Pascale Pouzet
Hisato Kitagawa
Ikunobu Muramatsu
Kenji Sakai
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ECSP034517A publication Critical patent/ECSP034517A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a derivados de m-amino-fenilimino-imidazolidina con un nuevo patrón de sustituyentes en el anillo de fenilo, a su uso para la preparación de medicamentos, en especial para el tratamiento de incontinencia de orina y a procedimientos de preparación de los mismos.
EC2003004517A 2000-10-14 2003-03-17 Nuevos derivados de m-amino-fenil-imino-imidazolidina para el tratamiento de la incontinencia de orina ECSP034517A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10051005 2000-10-14

Publications (1)

Publication Number Publication Date
ECSP034517A true ECSP034517A (es) 2003-04-25

Family

ID=7659815

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004517A ECSP034517A (es) 2000-10-14 2003-03-17 Nuevos derivados de m-amino-fenil-imino-imidazolidina para el tratamiento de la incontinencia de orina

Country Status (23)

Country Link
EP (1) EP1328517A2 (es)
JP (1) JP2004511547A (es)
KR (1) KR20030046503A (es)
CN (1) CN1471514A (es)
AR (1) AR035923A1 (es)
AU (1) AU2002215943A1 (es)
BG (1) BG107711A (es)
BR (1) BR0114603A (es)
CA (1) CA2425563A1 (es)
CZ (1) CZ20031333A3 (es)
DE (1) DE10150312A1 (es)
EA (1) EA200300460A1 (es)
EC (1) ECSP034517A (es)
EE (1) EE200300177A (es)
HU (1) HUP0302245A3 (es)
IL (1) IL155338A0 (es)
MX (1) MXPA03003162A (es)
NO (1) NO20031697L (es)
PL (1) PL361359A1 (es)
SK (1) SK4342003A3 (es)
WO (1) WO2002032876A2 (es)
YU (1) YU28203A (es)
ZA (1) ZA200302345B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz

Also Published As

Publication number Publication date
KR20030046503A (ko) 2003-06-12
EP1328517A2 (de) 2003-07-23
IL155338A0 (en) 2003-11-23
AR035923A1 (es) 2004-07-28
SK4342003A3 (en) 2003-10-07
MXPA03003162A (es) 2004-12-06
AU2002215943A1 (en) 2002-04-29
YU28203A (sh) 2006-05-25
BR0114603A (pt) 2003-10-14
EE200300177A (et) 2003-08-15
WO2002032876A2 (de) 2002-04-25
CN1471514A (zh) 2004-01-28
EA200300460A1 (ru) 2004-02-26
HUP0302245A2 (hu) 2003-10-28
PL361359A1 (en) 2004-10-04
CZ20031333A3 (cs) 2003-08-13
NO20031697L (no) 2003-05-26
BG107711A (bg) 2004-02-27
JP2004511547A (ja) 2004-04-15
NO20031697D0 (no) 2003-04-11
DE10150312A1 (de) 2002-07-04
HUP0302245A3 (en) 2004-01-28
CA2425563A1 (en) 2002-04-25
ZA200302345B (en) 2004-04-23
WO2002032876A3 (de) 2002-07-18

Similar Documents

Publication Publication Date Title
DOP2002000433A (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso
UY27571A1 (es) 2-tio-3, 5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
BRPI0408024A (pt) combinações antineoplásicas, compreendendo um derivado de rapamicina e um inibidor de aromatase
PT1351958E (pt) Imidazolo-5-il-2-anilino-pirimidinas como agentes para a inibicao da proliferacao celular
ATE302775T1 (de) Carbolinderivate
HN2000000267A (es) Oxazolidinonas substituidas y su uso
UY27604A1 (es) Compuestos químicos.
ATE346067T1 (de) Carbolinderivate
BR0107770A (pt) Derivados de 3-fenóxi-1-fenil acetileno e seu uso como herbicidas
UY29213A1 (es) Derivados de quinolina e isoquinolina 5-sustitiuidos, un procedimiento para su preparación y su uso como inhibidores de la inflamación
AR040130A1 (es) Esteres de etonogestrel, su uso como anticopceptivo y para el tratamiento de desordenes ginecologicos
UY28622A1 (es) Agentes antibacterianos de quinolona
ATE302776T1 (de) Kondensierte pyridoindolderivate
ATE259813T1 (de) Triazolopyrimidinderivate
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
ECSP034517A (es) Nuevos derivados de m-amino-fenil-imino-imidazolidina para el tratamiento de la incontinencia de orina
SV2006002220A (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios ref. p-sv-78.836/cd
HN2000000056A (es) Nuevas formas cristalinas de un antibiotico macrolido
UY26961A1 (es) Nuevos derivados de m-amino-fenil-imino-imidazolidina para el tratamiento de la incontinencia de orina
CR8162A (es) Piridinylanilides
ES2166026T3 (es) Derivados de 1,2,3-benzotiadiazol y su uso como microbicidas.
ECSP034632A (es) Uso de compuestos del 6-dimetilaminometil-1-fenil-ciclohexaco sustituido en la terapia de la incontinencia urinaria
CO5550429A2 (es) Formulaciones de lactona y metodos de uso
ECSP034700A (es) Nuevos derivados de m-alquil-fenilimino-imidazolidana para tratar la incontinencia urinaria
AR021616A1 (es) Cicloheptenos sustituidos, procedimiento para su preparacion y uso de los mismos.